Approval Trackers
Status pages and timeline pages for investigational obesity compounds, built for questions where the answer changes as filings, readouts, and label decisions move.
What belongs in this cluster
This hub is for pages that answer a single freshness-sensitive question: approved or not, filed or not, when the next decision window is, and which programme milestone matters most right now. The goal is clarity rather than speculation.
- Use the single-compound status pages when the query is specific to one asset.
- Use the master trackers when the query spans multiple compounds or compares timelines.
- Use the UAE trial-status page when a local clinical-trial question appears in the search path.
Status first
These pages are written to answer whether a compound is approved, filed, in trial, or still investigational before any regional availability framing enters the page.
Evidence stack
The approval cluster works best when it stays linked to source rules, editorial policy, and the broader research hub.
Flagship trackers
Start here for the primary approval and trial pages that anchor the 2026 obesity-pipeline narrative.
Is Retatrutide Approved?
Direct answer page for Retatrutide across FDA, EMA, and MoHAP contexts with the current filing window summarized plainly.
TRIUMPH Trial Tracker
Single index for programme milestones, readout timing, and what matters most in the path from Phase 3 to filing.
Obesity Drug Approval Tracker 2026
Portfolio-level page that compares approved drugs, filing candidates, and late-stage programmes on a shared timeline.
Clinical Trials UAE
Local-trials read on Retatrutide and related programmes for queries that mix compound status with UAE visibility.
Adjacent compound status pages
These pages cover the neighbouring assets most often compared against Retatrutide in approval-intent searches.
Is CagriSema Approved?
NDA-status and decision-window page for the amylin plus GLP-1 combination in late-stage development.
Is Survodutide Approved?
Status page for the dual GLP-1 and glucagon agonist, with a tight view of SYNCHRONIZE milestones.
Is Orforglipron Approved?
Approval-status page built around the oral non-peptide GLP-1 narrative and how it differs from injectable pipelines.
Foundayo / Orforglipron FDA Approved
The decision-focused page for readers searching the exact approval outcome rather than the broader status question.
Is Oral VK2735 Approved?
Status page for a newer oral-candidate query pattern that sits adjacent to Orforglipron search intent.